Janne Backman


Latest publications

  1. In Vitro Screening of Six Protein Kinase Inhibitors for Time-Dependent Inhibition of CYP2C8 and CYP3A4: Possible Implications with regard to Drug-Drug Interactions

    Filppula, A. M., Mustonen, T. M. & Backman, J. T., Dec 2018, In : Basic & Clinical Pharmacology & Toxicology. 123, 6, p. 739-748 10 p.

    Research output: Contribution to journalArticleScientificpeer-review

  2. Voriconazole greatly increases the exposure to oral buprenorphine

    Fihlman, M., Hemmilä, T., Hagelberg, N. M., Backman, J. T., Laitila, J., Laine, K., Neuvonen, P. J., Olkkola, K. T. & Saari, T. I., Dec 2018, In : European Journal of Clinical Pharmacology. 74, 12, p. 1615-1622 8 p.

    Research output: Contribution to journalArticleScientificpeer-review

  3. Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8-Mediated Metabolism of Montelukast in Humans.

    Itkonen, M. K., Tornio, A., Filppula, A. M., Neuvonen, M., Neuvonen, P. J., Niemi, M. & Backman, J. T., Sep 2018, In : Clinical Pharmacology and Therapeutics. 104, 3, p. 495-504 10 p.

    Research output: Contribution to journalArticleScientificpeer-review

View all (175) »

Latest activities

  1. Non-CYP Related Metabolic DDIs with Particular Emphasis on UGT-based DDIs

    Janne Backman (Invited speaker)
    24 Jun 201827 Jun 2018

    Activity: Talk or presentation typesInvited talk

  2. First Nordic Conference on Personalized Medicine

    Janne Backman (Member of organizing committee)
    30 May 20181 Jun 2018

    Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

  3. University of Eastern Finland (External organisation)

    Janne Backman (Expert)
    Mar 2018Jul 2018

    Activity: Membership typesAssessment of candidates for academic posts

View all (158) »

ID: 40487